Cervical dysplasia, also known as cervical intraepithelial neoplasia (CIN), causes abnormal cell growth that occurs on the epithelial lining of the cervix.
This report contains market size and forecasts of Cervical Dysplasia Diagnostic in Global, including the following market information:
Global Cervical Dysplasia Diagnostic Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Cervical Dysplasia Diagnostic market was valued at 489.1 million in 2021 and is projected to reach US$ 681.9 million by 2028, at a CAGR of 4.9% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Diagnostic Test Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Cervical Dysplasia Diagnostic include Abbott Laboratories, Roche Holding AG, Hologic, Inc., Micromedic Technologies Ltd., PDS Biotechnology Corporation, Quest Diagnostics, Inc. and QIAGEN N.V., etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Cervical Dysplasia Diagnostic companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cervical Dysplasia Diagnostic Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Cervical Dysplasia Diagnostic Market Segment Percentages, by Type, 2021 (%)
Diagnostic Test
Diagnostic Device
Global Cervical Dysplasia Diagnostic Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Cervical Dysplasia Diagnostic Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinic
Others
Global Cervical Dysplasia Diagnostic Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Cervical Dysplasia Diagnostic Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cervical Dysplasia Diagnostic revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Cervical Dysplasia Diagnostic revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott Laboratories
Roche Holding AG
Hologic, Inc.
Micromedic Technologies Ltd.
PDS Biotechnology Corporation
Quest Diagnostics, Inc.
QIAGEN N.V.